Subscribe to RSS
DOI: 10.1055/a-2615-4682
Association of fibrinogen variants with severity of obesity and metabolic liver disease: 2-year follow-up after bariatric surgery
Supported by: Department of Regional Health Research, University of Southern DenmarkSupported by: The Danish National Research Foundation
Supported by: The Region of Southern Denmark
Clinical Trial: Registration number (trial ID): NCT03535142, Trial registry: ClinicalTrials.gov (http://www.clinicaltrials.gov/), Type of Study: Prospective

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the hepatic manifestation of obesity. Studies in mice link fibrinogen variation to obesity and MASLD, but how naturally occurring fibrinogen variants associate with obesity and MASLD in humans is unknown. Objectives: To investigate associations of fibrinogen variants (fibrinogen γ’, fibrinogen αE, and sialylated fibrinogen) with obesity, MASLD, and fibrosis severity and examine changes in variants 2 years after bariatric surgery. Methods: We included 195 individuals with a BMI>35 kg/m2. A subgroup of 93 individuals, who underwent bariatric surgery (n=35) or served as non-surgical control group (n=58), were followed for 2 years. Hepatic tissue samples were scored for MASLD and fibrosis. Fibrinogen variants were measured using ELISA. Results: Absolute levels of fibrinogen variants tended to be higher in individuals with BMI>45 kg/m2 compared with BMI<40 kg/m2 (Δγ’: 70 (95% CI -19;160) µg/mL; ΔαE: 0.85 (-0.36;2.06) µg/mL; Δsialylated: 0.09 (-0.05;0.24) AU). Absolute and relative fibrinogen αE levels increased with MASLD (ΔαE: 2.04 (0.74;3.35) µg/mL; ΔαE ratio: 0.05 (0.02;0.08) %) and fibrosis (ΔαE: 1.79 (0.48;3.11) µg/mL; ΔαE ratio: 0.05 (0.02;0.07) %), while relative fibrinogen γ’ levels decreased with fibrosis (Δγ’ ratio: -2.52 (-4.70;-0.35) %). After bariatric surgery, sialylated fibrinogen levels were lower (Δsialylated: -0.22 (-0.32;-0.11) AU), but relative levels of the fibrinogen variants were higher (Δγ’: 1.7 (0.03;3.30) %; ΔαE: 0.03 (0.001;0.06) %; Δsialylated: 0.02 (0.002;0.04) AU/g/L) compared with the control group. Conclusion: Obesity, MASLD, and fibrosis alter fibrinogen variant profiles in plasma suggesting that fibrinogen variation plays a role in these inflammatory conditions.
Publication History
Received: 20 January 2025
Accepted after revision: 18 May 2025
Accepted Manuscript online:
19 May 2025
© . Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany